Jump to content

Fasinumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 18:33, 19 November 2015 (Identifier not assigned: use =none (CAS RN, ChemSpider, ATC) (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Fasinumab
Monoclonal antibody
Type?
SourceHuman
TargetHNGF
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
Chemical and physical data
FormulaC6406H9896N1700O2026S46
Molar mass144.6 kDa g·mol−1

Fasinumab is a human monoclonal antibody designed for the treatment of pain.[1] Fasinumab for acute sciatic pain[2]

This drug was developed by Regeneron Pharmaceuticals.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Fasinumab, American Medical Association.
  2. ^ http://www.dovepress.com/fasinumab-regn475-an-antinerve-growth-factor-monoclonal-antibody-for-t-peer-reviewed-article-JPR




Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Fasinumab&oldid=691418847"